To bleed or not to bleed? is that the question for the PTT?
Is aspirin effective in diabetic patients? Yes
Is aspirin effective in diabetic patients? No
von Willebrand disease – the relevance of history
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease
Post-translational modifications in proteins involved in blood coagulation
Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin
Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype
Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography
The post-thrombotic syndrome
Comparison of cell-surface TFPIα and β
von Willebrand factor ristocetin cofactor (VWF
Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen binding
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation
Chemically modified thrombin and anhydrothrombin that differentiate macromolecular substrates of thrombin
Proteolytic cleavage of protein S during the hemostatic response
Anti-inflammatory effect of activated protein C in gastric epithelial cells
Factor V Leiden improves in vivo hemostasis in murine hemophilia models
Role of coagulation FVIII in septic peritonitis assessed in hemophilic mice
Modulation of TAFI function through different pathways – implications for the development of TAFI inhibitors
The phospholipid composition and cholesterol content of platelet-derived microparticles
A 13-bp deletion in αIIb gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombasthenia
Three novel β-propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro-αIIb, but variably impaired progression of pro-αIIbβ3 from endoplasmic reticulum to Golgi
Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin
The role of γ-carboxylation in the anti-apoptotic function of gas6
Protease-activated receptors-1 and -2 can mediate endothelial barrier protection
Thrombolytic therapy in acute myocardial infarction
Thrombolytic therapy in acute myocardial infarction
Common genomic sequence variation of the prothrombin gene and risk of non-fatal myocardial infarction in white women
The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure
Development of antibodies specific to polyanion-modified platelet factor 4 during treatment with fondaparinux
The functional -4C>T polymorphism of the coagulation factor XII gene is not associated with deep venous thrombosis
Low levels of protein Z and the risk of venous thromboembolism
Carboxypeptidase B2 gene polymorphisms and the risk of venous thromboembolism
Rapid single-step detection of the inversion hotspot of mutation in hemophilia A by real-time PCR
Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes
More on
Talking about…